Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2024)

cbdMD's Asset Writedowns and Impairment history spans 6 years, with the latest figure at $921314.0 for Q3 2024.

  • For Q3 2024, Asset Writedowns and Impairment rose 229.87% year-over-year to $921314.0; the TTM value through Sep 2024 reached $921314.0, up 229.87%, while the annual FY2025 figure was $365979.0, 60.28% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2024 was $921314.0 at cbdMD, up from -$709393.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $60.1 million in Q3 2022 and bottomed at -$709393.0 in Q3 2023.
  • The 4-year median for Asset Writedowns and Impairment is $118210.0 (2020), against an average of $12.1 million.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 101.18% in 2023 before it soared 229.87% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $118210.0 in 2020, then skyrocketed by 50722.97% to $60.1 million in 2022, then crashed by 101.18% to -$709393.0 in 2023, then skyrocketed by 229.87% to $921314.0 in 2024.
  • Per Business Quant, the three most recent readings for YCBD's Asset Writedowns and Impairment are $921314.0 (Q3 2024), -$709393.0 (Q3 2023), and $60.1 million (Q3 2022).